Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionClean Yield Group
Latest Disclosed Ownership322 shares
Latest Disclosed Value $ 143,786
Clean Yield Group ownership in 1VRTX / Vertex Pharmaceuticals Incorporated

On April 14, 2026 - Clean Yield Group filed a 13F-HR form disclosing ownership of 322 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $122,231 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 322 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $117,949 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 322 0 0.00 144 -1.38 0.0405
2026-01-26 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 322 0 0.00 146 15.08 0.0405
2025-10-23 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 322 0 0.00 126 -11.89 0.0356
2025-07-17 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 322 -4 -1.23 143 -9.49 0.0429
2025-04-14 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 326 11 3.49 158 25.40 0.0515
2025-01-13 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 315 -3 -0.94 127 -14.29 0.0403
2024-10-07 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 318 10 3.25 148 2.08 0.0469
2024-07-10 2024-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 308 8 2.67 144 15.20 0.0539
2024-05-29 2024-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 125 2.46 0.0488
2024-01-24 2023-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 122 11.93 0.0514
2023-10-12 2023-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 110 3.81 0.0486
2023-07-26 2023-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 106 11.70 0.0435
2023-04-26 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 95 9.30 0.0403
2023-01-31 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 -11 -3.54 87 -4.44 0.0372
2022-10-31 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 311 11 3.67 90 5.88 0.0418
2022-07-18 2022-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 85 8.97 0.0351
2022-04-25 2022-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 78 18.18 0.0275
2022-01-24 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 66 22.22 0.0211
2021-10-27 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 54 -10.00 0.0177
2021-07-26 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 300 60 0.0204
2021-04-26 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 0 -300 -100.00 0 -100.00
2021-01-26 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 71 -13.41 0.0255
2020-10-16 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 82 -5.75 0.0332
2020-07-22 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 87 22.54 0.0376
2020-04-20 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 71 7.58 0.0337
2020-01-17 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 66 29.41 0.0207
2019-10-23 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 0 0.00 51 -7.27 0.0168
2019-07-22 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 300 300 55 0.0199
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.